Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 13, 2026 07:59 ET | Source: Posit Science

De-Fusing the Growing HIV-Dementia Time Bomb

SAN FRANCISCO, April 13, 2026 (GLOBE NEWSWIRE) -- Some 45 years ago, the first cases of AIDS appeared in New York, and then, everywhere. Three years later, Human Immunodeficiency Virus (HIV) was...
April 13, 2026 07:45 ET | Source: Firefly Neuroscience, Inc.

With Brain Scan Volume Momentum Accelerating, Firefly Makes History by Building the World’s First Known 200,000+ Standardized EEG/ERP Depository

- Firefly’s total brain scan volumes have increased sequentially by higher percentages in each of the past four quarters - - Firefly is harnessing increased data and NVIDIA L40S GPU acceleration to...
April 01, 2026 08:30 ET | Source: Actinogen Medical

Actinogen commences open-label phase of XanaMIA Alzheimer’s trial and provides business update

SYDNEY, April 01, 2026 (GLOBE NEWSWIRE) -- Actinogen Medical Limited (ASX: ACW) announces that the first participant has been treated in the open-label extension (OLE) phase of the XanaMIA trial...
February 18, 2026 08:00 ET | Source: Posit Science

The “Astonishing” Results of the Alzheimer’s Prevention Study Garnering Global Attention Were Foreseeable

SAN FRANCISCO, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Over the past week, news stories on the “surprising” findings of the ACTIVE Study on dementia garnered headlines around the globe. The 20-year,...
February 18, 2026 07:23 ET | Source: Constant Therapy Health

Constant Therapy Health Joins American Heart Association Innovators’ Network to Advance AI‑Driven Neurorehabilitation

Constant Therapy Health joins American Heart Association Innovators' Network as new stroke guidelines highlight importance of early intervention.
February 09, 2026 07:00 ET | Source: Posit Science

First Intervention Shown to Lower Alzheimer’s and Dementia Incidence

20-year large NIH-funded study finds one type of cognitive training reduces incidence of diagnosed dementia - exercise available only in BrainHQ
February 02, 2026 08:00 ET | Source: Actinogen Medical

Actinogen receives positive Interim Analysis recommendation from its independent Data Monitoring Committee to continue the XanaMIA pivotal Alzheimer’s disease trial

SYDNEY, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Actinogen Medical Limited (ASX: ACW) announces that the XanaMIA pivotal Alzheimer’s disease (AD) trial’s independent Data Monitoring Committee (DMC) has...
January 30, 2026 05:38 ET | Source: Research and Markets

Neurological Disorder Diagnostics Research Report 2026 - Global $17.32 Bn Market Trends, Opportunities, and Forecasts to 2031

Dublin, Jan. 30, 2026 (GLOBE NEWSWIRE) -- The "Neurological Disorder Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...
January 27, 2026 07:30 ET | Source: Cognition Therapeutics, Inc.

Cognition Therapeutics Completes Type C Meeting with FDA for Zervimesine (CT1812) in Dementia with Lewy Bodies

PURCHASE, N.Y., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative...
January 19, 2026 07:00 ET | Source: Peak Human

Dr. Sanjeev Goel, M.D.'s 20-Year Mission: Racing Against Genetic Alzheimer's Risk to Find Answers for Millions

Dr. Sanjeev Goel, M.D.'s 20-Year Mission: Racing Against Genetic Alzheimer's Risk to Find Answers for Millions